Tomas Luyten Selected Research

Tomas Luyten Research Topics

6	Neoplasms (Cancer) 01/2023 - 08/2013
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 06/2017
2	Starvation 06/2017 - 12/2011
1	Crohn Disease (Crohn's Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 10/2022
1	Kidney Diseases (Kidney Disease) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Cystinosis 10/2016
1	Breast Neoplasms (Breast Cancer) 08/2015
1	Carcinoma (Carcinomatosis) 08/2013
1	Colonic Neoplasms (Colon Cancer) 08/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2017
2	Inositol 1,4,5-TrisphosphateIBA 01/2018 - 06/2017
2	Peptides (Polypeptides)IBA 01/2018 - 01/2013
2	venetoclaxIBA 06/2017 - 08/2016
1	Leucine (L-Leucine)FDA Link 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Myosin-Light-Chain KinaseIBA 10/2022
1	ML 9IBA 10/2022
1	Apolipoprotein L1IBA 01/2020
1	ActomyosinIBA 01/2020
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 06/2017
1	Cystine (L-Cystine)IBA 10/2016
1	2-aminoethyl diphenylborinateIBA 08/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2013
1	ThapsigarginIBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013
1	CurcuminIBA 08/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Toxic ActionsIBA 01/2013
1	Beclin-1IBA 12/2011
1	Chelating AgentsIBA 12/2011
1	xestospongin BIBA 12/2011
1	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA 12/2011
1	Small Interfering RNA (siRNA)IBA 12/2011